Tranexamic Acid in the Management of Hemoptysis: Pharmacology, Administration Routes, Clinical Evidence, and Practical Considerations
Cureus · 13.05.2026
DOI: 10.7759/cureus.108790 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Cureus, erschienen am 13.05.2026. Verfasst von Stephanie R Schmalzried und 2 weiteren Autor:innen. Beteiligte Einrichtung: Pharmacology, Parkview Health, Fort Wayne, USA. Die Arbeit nennt 33 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Pharmacology, Parkview Health, Fort Wayne, USA.
- Internal Medicine, Parkview Health, Fort Wayne, USA.
- Pulmonary and Critical Care Medicine, Parkview Health, Fort Wayne, USA.
Zitieren
APA
Schmalzried, S. R., Munir, M., & Bajantri, B. (2026). Tranexamic Acid in the Management of Hemoptysis: Pharmacology, Administration Routes, Clinical Evidence, and Practical Considerations. Cureus. https://doi.org/10.7759/cureus.108790
Vancouver
Schmalzried SR, Munir M, Bajantri B. Tranexamic Acid in the Management of Hemoptysis: Pharmacology, Administration Routes, Clinical Evidence, and Practical Considerations. Cureus. 2026. doi:10.7759/cureus.108790
BibTeX
@article{Schmalzried2026,
author = {Schmalzried, Stephanie R and Munir, Muneebah and Bajantri, Bharat},
title = {Tranexamic Acid in the Management of Hemoptysis: Pharmacology, Administration Routes, Clinical Evidence, and Practical Considerations},
journal = {Cureus},
year = {2026},
doi = {10.7759/cureus.108790}
}
EUVIMED